Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Bcl-xL and Mcl-1 cooperate to protect cancer cells against apoptosis and their concomitant inhibition leads to massive apoptosis even in the absence of chemotherapy
Formula: C27H30F3N9O
16-trioxa-2
and inhibits the production of interleukin-1 (IL-1)
Sunitinib Malate Size:Solid 2 mg Bcl-xL and Mcl-1 cooperate toSunitinib, also known as SU11248, is the orally bioavailable malate salt of an indolinone based tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet derived
US$ 712.50
US$ 40.00
US$ 1193.00
US$ 139.50
US$ 646.00
US$ 131.50
US$ 646.00
US$ 139.50
US$ 25.00
US$ 40.00
US$ 40.00